T1	Participants 207 388	24 patients with endstage chronic renal failure and pericarditis randomly received indomethacin, 25 mg four times daily, (11 patients) or a placebo (13 patients) for a 3-week period
T2	Participants 390 402	All patients
T3	Participants 1128 1207	two patients treated with indomethacin and one patient who received the placebo
